Please login to the form below

Not currently logged in
Email:
Password:

pancrelipase

This page shows the latest pancrelipase news and features for those working in and with pharma, biotech and healthcare.

Allergan eyes early 2017 European launch for Enzepi

Allergan eyes early 2017 European launch for Enzepi

Allergan's Enzepi (pancrelipase) has been recommended for European approval to treat exocrine pancreatic insufficiency (EPI) in patients with conditions such as cystic fibrosis.

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    Pancreatic enzyme replacement therapy Creon (pancrelipase) grew 20 per cent to $106m while Zemplar (paricalcitol) for hyperparathyroidism was up 12.5 per cent to $63m, reversing first -quarter declines as AbbVie

  • AbbVie expects Humira to drive growth in inaugural guidance AbbVie expects Humira to drive growth in inaugural guidance

    Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism

  • Abbott wins FDA approval for infant CF dose

    Abbott wins FDA approval for infant CF dose. Abbott has secured approval for an infant-specific dose of CREON (pancrelipase) to treat exocrine pancreatic insufficiency caused by cystic fibrosis (CF). ... Abbott has secured Food and Drug Administration

  • Breathing easier

    Canada . Pancrelipase . Zenpep (Eurand). Pancreatic disorders . US. Telmisartan/amlodipine. Twynsta (Boehringer Ingelheim).

  • J&J's enzyme treatment approved

    The US Food and Drug Administration (FDA) has announced the approval of Pancreaze (pancrelipase), Johnson &Johnson's (J&J) pancreatic enzyme product (PEP) available as a delayed release capsule. ... This is the third approval for a PEP by the FDA since

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics